Campbell & Co Investment Adviser’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,506
| Closed | -$678K | – | 1139 |
|
|
2024
Q2 | $678K | Buy |
+12,506
| New | +$678K | 0.06% | 529 |
|
|
2023
Q4 | – | Sell |
-28,159
| Closed | -$830K | – | 1144 |
|
|
2023
Q3 | $830K | Buy |
28,159
+14,180
| +101% | +$418K | 0.1% | 332 |
|
|
2023
Q2 | $456K | Buy |
+13,979
| New | +$456K | 0.08% | 481 |
|
|
2022
Q3 | – | Sell |
-20,328
| Closed | -$799K | – | 748 |
|
|
2022
Q2 | $799K | Buy |
+20,328
| New | +$799K | 0.22% | 131 |
|
|
2019
Q2 | – | Sell |
-43,844
| Closed | -$355K | – | 563 |
|
|
2019
Q1 | $355K | Buy |
+43,844
| New | +$355K | 0.17% | 221 |
|
|
2017
Q1 | – | Sell |
-10,500
| Closed | -$128K | – | 163 |
|
|
2016
Q4 | $128K | Buy |
+10,500
| New | +$128K | 0.4% | 112 |
|